New blood test aims to improve cervical cancer detection
NCT ID NCT07480902
Summary
This study aims to compare the effectiveness of the standard Pap smear test with a new blood test for detecting abnormal cervical cells and early signs of cervical cancer. Researchers will enroll 558 women aged 18-85 to undergo both tests, along with a detailed colposcopy exam. The goal is to see if the new molecular blood test can be a useful tool for screening.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for I) ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE (ASC-US) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Consultorio Médico TIMSER
RECRUITINGMexico City, Mexico City, 14210, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.